Midwife Licensure Exam Research & Evidence-Based Practice — Nursing Research Process & Evidence-Based PracticeStudy Notes

Nursing research is a systematic, rigorous inquiry designed to develop, refine, and expand nursing knowledge that improves patient care. Unlike casual problem-solving or trial-and-error practice, research uses formal methods to identify, describe, explain, predict, and control phenomena relevant to nursing. Research serves multiple critical purposes: it generates evidence to improve clinical outcomes, supports sound decision-making at the bedside and in policy, informs the development of evidence-based practice guidelines, and strengthens the professional autonomy and credibility of nursing. In the Philippines, the Board of Nursing (BON) under the Professional Regulation Commission (PRC) expects registered nurses to demonstrate competence as research consumers and, ideally, as research participants who contribute to the generation of local evidence. Nursing research addresses diverse questions—How effective is this new wound dressing? What is the lived experience of patients with chronic illness? How do cultural factors influence medication adherence in our population? Research thus serves not only to test established theories but also to explore new understandings of nursing phenomena, making it central to improving the quality and culturally congruent nature of care in Philippine health systems.

The quantitative research process follows a logical, orderly sequence from problem identification through dissemination. Understanding this sequence is critical for critiquing published research and recognizing the rigor applied to a study. Step 1: Identify and State the Problem—the researcher identifies a gap in knowledge or a clinical problem worth investigating. This problem statement must be clear, specific, and significant to nursing practice. For example, 'What is the effect of early mobilization on the incidence of venous thromboembolism in post-operative cardiac patients?' Step 2: Review the Literature—the researcher systematically searches published and unpublished sources to learn what is already known about the topic, identify gaps, and situate the new study within existing knowledge. A well-conducted literature review in the Philippines might include databases like PUBMED, CINAHL, the WHO Western Pacific Regional Office publications, and local nursing journals. Step 3: Formulate the Theoretical or Conceptual Framework—the researcher selects or develops a theoretical lens (such as Roy's Adaptation Model, Orem's Self-Care Theory, or the Health Belief Model) that guides the study design and interpretation of findings. Step 4: State Research Questions, Objectives, or Hypotheses—these are specific, measurable statements of what the study aims to determine. Research questions are typically used in exploratory studies; hypotheses are used in hypothesis-testing research. Step 5: Select the Research Design and Methodology—the researcher chooses an appropriate quantitative design (e.g., experimental, quasi-experimental, descriptive, correlational) based on the research question and feasibility. Step 6: Identify the Population and Sample—the researcher defines the target population and selects a sample using an appropriate sampling method. A larger, representative sample increases the ability to generalize findings. Step 7: Collect Data—data are gathered using valid and reliable instruments (questionnaires, structured interviews, biophysiologic measures, or existing records). Data collection must be standardized to reduce bias. Step 8: Analyze Data—raw data are organized and analyzed using appropriate statistical methods (descriptive and inferential statistics) to answer the research questions or test hypotheses. Step 9: Interpret Findings and Draw Conclusions—the researcher explains what the results mean, discusses how findings relate to the framework and literature, acknowledges limitations, and suggests implications for practice and future research. Step 10: Communicate and Disseminate—findings are shared through peer-reviewed journals, conferences, practice settings, and policy forums so they can be applied and scrutinized. In Philippine contexts, dissemination through the Philippine Nursing Association (PNA) meetings, regional nursing conferences, and local health department forums is common.

Variables are characteristics or attributes that vary (change) among individuals or observations. Understanding variables is fundamental to research design and interpretation. The Independent Variable (IV) is the presumed cause, condition, or intervention that is manipulated or examined. It is what the researcher changes or exposes participants to. For example, in a study of the effect of structured patient education on diabetes self-management, the structured patient education program is the IV. The Dependent Variable (DV) is the presumed effect or outcome that is measured or observed. It is what changes (or is expected to change) as a result of the IV. In the diabetes example, diabetes self-management knowledge and behavior are the DVs. A well-designed study clearly identifies and operationalizes (defines in measurable terms) both variables. A Hypothesis is a testable prediction or proposed relationship between variables. The Null Hypothesis (H0) states that there is no relationship, no difference, or no effect between variables; it is a statement of no change. Statistical testing in quantitative research attempts to reject the null hypothesis. For example, H0: There is no difference in infection rates between patients who receive standard wound care and those who receive enhanced antiseptic care. The Alternative Hypothesis or Research Hypothesis (H1 or Ha) states that there is a relationship or difference; it predicts the direction and nature of the relationship. For example, H1: Patients who receive enhanced antiseptic care will have lower infection rates than those who receive standard care. Directional hypotheses predict the direction of difference (e.g., 'enhanced care will result in LOWER rates'); non-directional hypotheses predict a difference but not its direction (e.g., 'there will be a DIFFERENCE in infection rates'). In research, hypothesis testing is not about proving the alternative hypothesis true; rather, it is about gathering evidence strong enough to reject the null hypothesis. If statistical testing yields a p-value less than 0.05, we reject the null hypothesis and conclude that there is sufficient evidence of a relationship or difference—but this does not 'prove' the alternative hypothesis is true; it simply indicates the relationship is unlikely to be due to chance alone.

Research approaches are fundamentally different in how they generate and interpret knowledge. Quantitative Research uses numerical measurement and statistical analysis to test hypotheses and identify generalizable, objective patterns. Quantitative researchers collect data that can be counted, measured, and analyzed using statistics; they test a priori hypotheses; they aim to generalize findings from the sample to the broader population. The approach is deductive—starting with theory or prior knowledge and testing whether it holds in the data. Quantitative studies ask questions like 'How much?' 'How many?' 'What is the relationship?' Examples include experiments testing the effect of an intervention on an outcome, surveys measuring prevalence of a condition, and correlational studies examining associations between variables. Qualitative Research, by contrast, explores meaning, experience, and process through narrative, text, or observation. Qualitative researchers immerse themselves in data to understand how people make sense of their world; they do not begin with a hypothesis but allow understanding to emerge (inductive). Qualitative questions ask 'What is the experience?' 'How do people understand this?' 'What is the process?' The approach is interpretive and focuses on depth and understanding rather than breadth and numbers. Qualitative research is invaluable for understanding phenomena that numbers alone cannot capture—the lived experience of chronic illness, the cultural beliefs influencing family health decisions, the process by which nurses learn to provide compassionate care. Qualitative research in nursing often uses specific traditions: Phenomenology explores the lived experience of a phenomenon (e.g., What is it like to be a family member of a patient with dementia?); Grounded Theory generates theory from data about social or psychological processes (e.g., How do patients adapt to long-term hospitalization?); Ethnography describes the culture, beliefs, and practices of a specific group (e.g., How do folk healers (albularyo) and formal health providers coexist in rural Philippine communities?); Case Study provides an in-depth, detailed examination of a single person, event, or organization. In the Philippines, qualitative research is increasingly used to understand the cultural context of health practices, barriers to accessing rural health services, and the patient's perspective on care quality—areas where quantitative data alone cannot provide sufficient insight. Both approaches are valuable; the choice depends on the research question. If you want to know how many people experience post-traumatic stress after a natural disaster, quantitative methods are appropriate. If you want to understand what that experience feels like and how people cope, qualitative methods are essential.

Quantitative research designs are classified by their ability to establish cause-and-effect relationships. This classification is crucial for appraising the strength of evidence a study provides. EXPERIMENTAL DESIGNS (True Experiments) are the gold standard for establishing causation. A true experiment has three defining characteristics—all three must be present: (1) Manipulation of the Independent Variable—the researcher actively assigns participants to receive or not receive the intervention (the IV is under the researcher's control); (2) Control Group—there is a comparison group that does not receive the intervention, allowing the researcher to compare outcomes between the group that received the intervention and the group that did not; (3) Randomization—participants are randomly assigned to either the intervention or control group, which distributes known and unknown confounding variables equally between groups and reduces selection bias. The Randomized Controlled Trial (RCT) is the most rigorous experimental design and is considered the 'gold standard' for testing the effectiveness of clinical interventions. Example: A researcher randomly assigns 100 post-operative patients to either receive early mobilization (intervention) or standard care (control); outcomes (e.g., rate of venous thromboembolism, length of stay) are measured and compared. Because randomization was used, the researcher can confidently conclude that any difference in outcomes was caused by the intervention, not by pre-existing differences between groups. QUASI-EXPERIMENTAL DESIGNS have manipulation of the IV but lack either randomization and/or a control group, making causal inference weaker. Despite the weaker causal inference, quasi-experimental designs are often more feasible in clinical settings where randomization is impractical or unethical. Types include: (1) Non-randomized Controlled Trials—participants are not randomly assigned but are allocated to intervention or control groups (e.g., assigning by clinic day, odd/even hospital record number); (2) One-Group Pretest-Posttest Design—a single group is measured before (pretest) and after (posttest) an intervention; outcomes are compared. A limitation is that changes may be due to time, maturation, or other factors, not the intervention. (3) Time-Series Design—a single group is measured multiple times before and after an intervention, strengthening the ability to infer causation by showing the timing of change coincides with the intervention. Example: A clinic implements a new protocol for hypertension management and measures blood pressure readings in all patients monthly for 6 months before and 6 months after implementation; the pattern of change (before stable, after improving) suggests the intervention caused improvement. NON-EXPERIMENTAL (OBSERVATIONAL) DESIGNS examine phenomena without manipulating variables and often lack control groups. These designs cannot establish cause and effect but are useful for describing phenomena, exploring relationships, or examining outcomes that cannot ethically be experimentally manipulated. Types include: (1) Descriptive Designs—describe the characteristics, frequency, or distribution of a phenomenon in a population. A descriptive survey might measure the prevalence of depression among nurses in the Philippines. Descriptive designs are the weakest for establishing relationships but provide essential baseline information. (2) Correlational Designs—examine the relationship between two or more variables without manipulating either. A correlational study might examine whether years of nursing experience correlate with job satisfaction. The correlation coefficient (r) ranges from −1 to +1 and indicates the strength and direction of the linear relationship, but correlation does not prove causation—this is a critical principle. (3) Cohort Studies (Prospective)—follow a group of participants over time to observe outcomes. Participants are typically classified by exposure (exposed vs. unexposed to a risk factor) and then followed forward to see who develops the outcome. Example: A prospective cohort study of 1,000 nurses follows those exposed to shift work and those not exposed to compare rates of developing sleep disorders over 2 years. Cohort studies provide stronger evidence of causation than correlational studies because exposure is documented before the outcome occurs. (4) Case-Control Studies (Retrospective)—compare individuals who have the outcome (cases) to those who do not (controls) and look backward to identify exposures or risk factors that differed between groups. Example: Researchers identify patients who developed hospital-acquired infection (cases) and matched controls without infection, then examine medical records to determine if antibiotic use differed between groups. Case-control studies are efficient for studying rare outcomes but provide weaker causal inference than cohort studies because exposure information is collected retrospectively and may be subject to recall bias. (5) Cross-Sectional Designs—collect data at a single point in time on both the exposure/characteristic and the outcome. Example: A survey of 200 nurses measures both stress levels and job satisfaction in a single session. Cross-sectional designs cannot establish temporal relationship (which came first?) and thus cannot establish causation. In appraising research, remember this hierarchy: True Experiments (with all three characteristics) provide the strongest evidence; Quasi-Experimental designs provide moderate evidence; Non-Experimental designs (correlational, cohort, case-control) provide weaker evidence of causation but are useful for description and exploration. The strongest evidence-based practice recommendations come from systematic reviews and meta-analyses of multiple RCTs.

Understanding population and sampling is essential for both conducting and appraising research. The Population is the entire group of individuals or units that meets specified criteria and to which findings are intended to apply. The Target Population is the population to which the researcher wants to generalize findings (e.g., all nurses in the Philippines working in primary health care settings). The Accessible Population is the portion of the target population that the researcher can realistically reach or access (e.g., nurses working in primary health care centers in Metro Manila). In most studies, researchers study the accessible population but hope to generalize to the target population; this requires that the accessible population is reasonably representative of the target population. A Sample is a subset of the population that is actually studied. Sampling is the process of selecting the sample. Sample size matters—larger, well-chosen samples generally reduce sampling error (the difference between the sample and population statistics) and increase the power to detect real effects. The adequacy of sample size depends on the research design, effect size expected, and acceptable level of error (alpha). Sampling methods are classified into two broad categories: PROBABILITY SAMPLING (Random Sampling) — each member of the population has a known, non-zero probability of being selected. Probability samples are more likely to be representative of the population and thus support generalizability. Types include: (1) Simple Random Sampling—every member of the population has an equal, independent chance of being selected. Example: Assigning all nurses in a hospital a number and using a random number generator to select 50 nurses. This is the most straightforward but may be impractical in large populations. (2) Systematic Sampling—every kth member of an ordered population list is selected (k is calculated by dividing the population size by desired sample size). Example: If a clinic has 500 patients and 100 are desired, every 5th patient (500 ÷ 100 = 5) on an alphabetical list is selected. Systematic sampling is practical and reduces bias if the list is not ordered by a characteristic related to the study variables. (3) Stratified Random Sampling—the population is divided into strata (subgroups) based on a characteristic relevant to the study (age, gender, health status), then random sampling occurs within each stratum to ensure representation. Example: Studying patient satisfaction in a hospital where different wards have different patient types; randomly sampling from each ward ensures all ward types are represented. This design is more likely to capture diversity and is particularly useful in the Philippines where regional and cultural diversity is significant. (4) Cluster (Multistage) Sampling—random selection of clusters (groups or geographic areas), then sampling within selected clusters. Example: Randomly selecting 10 barangays from the Philippines, then randomly selecting health centers within those barangays, then randomly selecting patients from those centers. Cluster sampling is efficient for large, geographically dispersed populations and is commonly used in national health surveys. NON-PROBABILITY SAMPLING — members do not have an equal or known chance of selection. Non-probability samples are easier and cheaper to obtain but are more prone to bias and do not support strong generalizability. Types include: (1) Convenience Sampling—selecting readily available subjects without systematic method. Example: Recruiting patients in a waiting room or nurses volunteering from an in-service training. Convenience sampling is quick but highly vulnerable to bias; samples may not represent the population. (2) Quota Sampling—convenience sampling with a preset number of participants in each subgroup. Example: Recruiting 25 hypertensive patients, 25 diabetic patients, and 25 with cardiovascular disease from a waiting room. While better than pure convenience sampling, quota sampling still relies on convenience within quotas. (3) Purposive (Judgmental) Sampling—the researcher hand-picks participants based on specific criteria or characteristics believed to be relevant to the study. Example: Selecting nurses known to be particularly experienced in wound care to provide expert opinion on dressing products. Purposive sampling is common in qualitative research and when specific expertise is needed but does not support generalization to the broader population. (4) Snowball (Network) Sampling—existing participants refer other potential participants, creating a chain-referral pattern. Example: Studying undocumented migrant workers and their health needs; initial participants refer others from their network. Snowball sampling is valuable for hard-to-reach or hidden populations but introduces selection bias because referred participants likely share characteristics with those who referred them. In the Philippines, where informal networks and community connections are strong, snowball sampling is often used in qualitative studies of marginalized groups. Generalizability (External Validity) is the degree to which findings can be applied beyond the study sample to the broader population. Probability sampling enhances generalizability; non-probability sampling limits it. When appraising research, recognize that studies using non-probability sampling cannot claim their findings generalize to the broader population but can still provide valuable insights, especially in qualitative research or when studying specific, defined groups. A high-quality study using convenience sampling may yield rich, relevant findings for a specific clinical setting; a poorly designed RCT may not. The sampling method must be judged in context of the research question and design.

Data collection is the process of gathering information to answer the research questions. The method chosen must be appropriate to the research design and capable of yielding valid, reliable data. COMMON DATA COLLECTION METHODS include: (1) Questionnaires—written instruments that participants complete independently. Questionnaires are efficient for gathering standardized information from large samples and reduce interviewer bias. Limitations include difficulty with complex or sensitive questions and lower response rates than interviews. (2) Structured Interviews—the researcher uses a standardized set of questions asked in the same order and manner to all participants. Structured interviews are consistent and easier to analyze but less flexible than unstructured interviews. (3) Unstructured Interviews—the researcher uses open-ended questions to explore topics in depth; the interview naturally flows based on participant responses. Unstructured interviews are valuable for qualitative research and understanding nuanced experiences but are harder to analyze and prone to interviewer bias. (4) Observation—the researcher observes and records behavior, activities, or events in natural or controlled settings. Structured observation uses predetermined categories; unstructured observation is more exploratory. Observation is valuable for understanding non-verbal behavior and context but is time-consuming and the presence of the observer may alter behavior (Hawthorne effect). (5) Biophysiologic Measures—direct measurement of physical parameters such as blood pressure, blood glucose, vital signs, or lab values. Biophysiologic measures are objective and reliable when equipment is calibrated and procedures are standardized. (6) Existing Records—data already collected for other purposes, such as medical records, hospital administrative data, or government health statistics. Using existing records is efficient and economical but data quality depends on how thoroughly the original data were collected. Two critical properties determine instrument quality: VALIDITY and RELIABILITY. VALIDITY is the degree to which an instrument measures what it is intended to measure. An instrument must be valid to produce meaningful results. Types of validity include: (1) Content Validity—does the instrument adequately represent all important dimensions of the concept being measured? A stress scale is content-valid if it measures physical, emotional, behavioral, and cognitive aspects of stress. Content validity is judged by experts (content validity index, CVI) or by literature review. (2) Construct Validity—does the instrument measure the theoretical construct it claims to measure? Does a 'patient empowerment scale' really measure empowerment and not just satisfaction or compliance? Construct validity is established through factor analysis, convergent/discriminant validity, and known-groups validity (do groups known to differ on the construct score differently on the instrument?). (3) Criterion-Related Validity—does the instrument correlate with an external criterion or gold standard? If a new, quick depression screening tool is being developed, criterion validity is established by comparing scores to a psychiatric diagnosis (gold standard). Predictive validity examines whether the instrument predicts future outcomes (e.g., does a pre-operative anxiety scale predict post-operative recovery time?). RELIABILITY is the degree to which an instrument yields consistent, reproducible results. A reliable instrument produces stable measurements over time and across raters or items. Types of reliability include: (1) Test-Retest Reliability—the instrument is administered to the same group at two different times; if results are consistent (high correlation between time 1 and time 2), the instrument is reliable over time. Test-retest reliability assumes the variable being measured has not actually changed. (2) Internal Consistency Reliability—do all items within an instrument measure the same construct? Cronbach's alpha is a common measure; values of 0.70 or higher are generally acceptable. An instrument with high internal consistency means items are homogeneous and measure one underlying construct. (3) Interrater (Interobserver) Reliability—if multiple raters use the instrument, do they obtain similar results? Example: Do five nurses rating a patient's pain on a numerical scale all rate it similarly? Interrater reliability is measured using percent agreement, Cohen's kappa, or intraclass correlation coefficient (ICC). A critical principle: An instrument can be reliable (consistent) without being valid (measuring what it should). A broken thermometer that always reads 38°C is reliable—it's consistent—but not valid for measuring actual temperature. Conversely, an instrument cannot be valid without being reliable; if an instrument is inconsistent, it cannot accurately measure anything. When appraising research, examine whether the researcher reported validity and reliability data for instruments. In the Philippines, instruments should be validated in the Filipino population; using an instrument validated only in Western populations may introduce cultural bias. Look for reliability coefficients (Cronbach's alpha, test-retest r, ICC) and evidence of validity (content, construct, criterion). For biophysiologic measures, look for evidence that equipment was calibrated and procedures were standardized.

Research ethics protect the dignity, rights, autonomy, and welfare of human research participants. The ethical framework guiding research is based on foundational principles articulated in the Belmont Report and expanded in nursing ethics. The Four Core Principles are: (1) Respect for Persons (Autonomy)—individuals are autonomous agents with the right to self-determination. Researchers must provide information and allow individuals to make voluntary decisions about participation. (2) Beneficence—researchers have an obligation to maximize benefits and minimize harms. Research should be designed to contribute to knowledge and improve care. (3) Nonmaleficence—the obligation to avoid harm (''first, do no harm''). Research risks must be justified by potential benefits. (4) Justice—fair distribution of research benefits and burdens. Vulnerable populations should not be preferentially enrolled in risky studies solely for convenience. Nursing ethics adds Fidelity—loyalty, honesty, and keeping commitments to research participants. KEY ETHICAL PROTECTIONS: Informed Consent is the cornerstone of research ethics. Informed consent means participants voluntarily agree to participate based on adequate understanding of: the purpose of the research, procedures they will undergo, foreseeable risks and discomforts, potential benefits, alternative procedures (if applicable), confidentiality protections, the right to ask questions, and the right to withdraw without penalty at any time. Consent must be documented, usually via a signed consent form. Special considerations apply to vulnerable populations: (1) Children—cannot provide informed consent; parental/guardian consent plus the child's assent (agreement, in child-appropriate language) are required. The child has the right to decline participation even if parents consent. (2) Pregnant Women—considered vulnerable; research is restricted to studies that do not increase risk to the fetus. (3) Prisoners—extra protections because autonomy is limited; research involving prisoners requires strict ethical review. (4) Cognitively Impaired Individuals—require proxy consent (family member or legal guardian); capacity to assent should be assessed and respected. (5) Critically Ill Patients—may lack capacity to provide informed consent; family or proxy decision-making and expedited review are appropriate. Confidentiality and Anonymity: Confidentiality means the researcher knows participants' identities but protects the information they provide; no one else has access to their data. Anonymity means participants' identities are unknown; data cannot be linked to individuals. In the Philippines, the Data Privacy Act of 2012 (RA 10173) mandates protection of personal information and imposes penalties for unauthorized disclosure. Researchers must secure data (locked files, encrypted digital data), limit access to authorized personnel, and de-identify data when possible (removing names and identifying information, replacing with codes). Protection from Harm involves: assessing and minimizing research risks, ensuring physical safety, protecting psychological well-being, and allowing participants to withdraw if harm occurs. Potential harms include physical injury, psychological distress, invasion of privacy, loss of confidentiality, and loss of opportunity cost (time away from other activities). The research should be designed to minimize risks; any remaining risks must be justified by potential benefits. Full Disclosure: Researchers must disclose all relevant information, including potential conflicts of interest. Deception (withholding relevant information) is only ethically acceptable in rare circumstances and must be approved by an ethics review committee. ETHICS REVIEW OVERSIGHT: All research involving human subjects must be reviewed and approved by an Institutional Review Board (IRB) or Research Ethics Committee before the study begins. The role of the IRB/Ethics Committee is to: Review the research protocol to ensure ethical principles are met, assess risks and benefits, examine informed consent procedures, ensure confidentiality protections, and verify that special protections for vulnerable populations are in place. In the Philippines, research ethics oversight follows guidelines from the National Ethical Guidelines for Health and Health-Related Research, developed by the Philippine Health Research Ethics Board (PHREB) under the Department of Science and Technology (DOST). Philippine researchers also adhere to the Code of Ethics of the Research Institute for Tropical Medicine and institutional guidelines. Any nursing research conducted in Philippine health facilities must be reviewed and approved by the facility's Ethics Review Committee. Nurses' Roles in Research Ethics: Nurses in clinical settings must: Understand research protocols and ensure ethical procedures are followed; Protect participants' rights during data collection; Recognize signs that a participant is experiencing harm or distress and report to the research team; Ensure confidentiality of research data; Advocate for vulnerable patients if coercion or inadequate protections are suspected; Report ethical violations to institutional leadership. Because nurses spend significant time with patients, they are often the first to notice if a participant is experiencing harm, distress, or coercion. Ethical vigilance is a professional responsibility.

Nurses do not need to perform complex statistical calculations, but they must interpret and understand what statistics mean to apply research findings appropriately. Understanding statistics enhances critical appraisal and improves clinical decision-making based on evidence. LEVELS OF MEASUREMENT determine which statistics are appropriate: (1) Nominal Data—categories with no order; examples include blood type (A, B, AB, O), sex (male, female), marital status, diagnosis. The only descriptive statistic appropriate is the mode (most frequent category) and frequency counts. (2) Ordinal Data—ordered categories but intervals between categories are not equal; examples include Likert scales (strongly disagree, disagree, neutral, agree, strongly agree), pain rating (0–10), education level (elementary, high school, college, graduate). Medians, percentiles, and frequency counts are appropriate; means are sometimes used but interpreted cautiously. (3) Interval Data—ordered categories with equal intervals between values, but no true zero; examples include temperature in Celsius (0°C is a point on the scale, not 'no temperature'). Means, standard deviations, and inferential statistics like t-tests and correlation are appropriate. (4) Ratio Data—equal intervals with a true zero (zero means none of the quantity); examples include weight (0 kg = no weight), height, pulse rate, blood pressure, age, number of medications. Ratio data can be analyzed with any statistic; means and standard deviations are appropriate and interpretable. DESCRIPTIVE STATISTICS summarize and describe data: (1) Measures of Central Tendency indicate the middle or typical value: The Mean (average) is calculated by summing all values and dividing by the number of values. The mean is sensitive to outliers and best for interval/ratio data that follow a normal distribution. Example: Patient pain scores (0–10 scale) on Day 1 post-op: 7, 8, 6, 9, 8, 7, 6. Mean = (7+8+6+9+8+7+6) ÷ 7 = 51 ÷ 7 = 7.3. The Median is the middle value when data are arranged in order; half of values are above it, half below. The median is not affected by outliers and is best for skewed data or ordinal data. Example: Using the same pain scores, arranging in order: 6, 6, 7, 7, 8, 8, 9. The median is 7 (the middle value). The Mode is the most frequent value; it is the only measure suitable for nominal data. Example: If in a sample of 20 nurses, 8 work day shift, 6 work evening, and 6 work night, the mode is day shift. Understanding which measure to use: For normally distributed interval/ratio data (e.g., age of a large random sample of patients), mean = median = mode and the mean is reported. For skewed data (e.g., income, which is often skewed with a few very high earners), the median may better represent the typical value than the mean (which is pulled toward outliers). For nominal data, only the mode is appropriate. (2) Measures of Variability describe how spread out the data are: The Range is the difference between the highest and lowest values. Example: If pain scores range from 2 to 10, the range is 8. The range is simple but affected by outliers. The Standard Deviation (SD) measures how far, on average, individual values deviate from the mean. A larger SD indicates greater spread; a smaller SD indicates values cluster closer to the mean. In a normal distribution, approximately 68% of values fall within ±1 SD of the mean, 95% fall within ±2 SD, and 99.7% fall within ±3 SD (the 68-95-99.7 rule). Example: If mean pain score is 7.3 and SD is 1.2, then about 68% of pain scores fall between 6.1 and 8.5 (7.3 ± 1.2). A normal (bell) distribution has the characteristic shape where mean = median = mode, and data are symmetrically distributed around the mean. Understanding variability is important: two studies might report the same mean blood pressure, but if one has a large SD (values widely spread) and the other a small SD (values closely grouped), the meanings differ. Patients in the low-SD group have more consistent control; those in the high-SD group have variable control despite the same average. INFERENTIAL STATISTICS allow researchers to generalize from a sample to a population and test hypotheses: (1) The p-value (probability value) is the probability that an observed result occurred by chance alone, assuming the null hypothesis is true. The conventional cutoff is p < 0.05 (read as 'p is less than 0.05'), meaning there is a less than 5% probability the result is due to chance. Results with p < 0.05 are considered statistically significant—we reject the null hypothesis and conclude there is sufficient evidence of a relationship or difference. Results with p ≥ 0.05 are not statistically significant; we fail to reject the null hypothesis. Importantly, statistical significance does not equal clinical significance. A study might find a statistically significant (p = 0.04) difference in average pain reduction between two groups (Group A: 5-point reduction vs. Group B: 4-point reduction on a 0–10 scale), but a 1-point difference may not be clinically meaningful to patients. (2) Type I Error (Alpha Error) is rejecting a true null hypothesis—concluding there is a difference when there actually is not (a false positive). The alpha level (usually 0.05) is the maximum acceptable probability of making a Type I error. (3) Type II Error (Beta Error) is failing to reject a false null hypothesis—concluding there is no difference when there actually is one (a false negative). Beta is related to statistical power (power = 1 − beta); higher power means lower risk of Type II error. (4) Common Inferential Tests: t-test compares the means of two groups. Example: comparing mean blood pressure between a group receiving an intervention and a control group. ANOVA (Analysis of Variance) compares the means of three or more groups. Chi-square test (χ²) examines associations between categorical variables. Example: examining if there is a relationship between gender (male/female—categorical) and hypertension status (yes/no—categorical). The result indicates whether the two variables are related; the larger the chi-square value, the stronger the association. Correlation coefficient (r) ranges from −1.0 to +1.0 and describes the linear relationship between two continuous variables. The sign (+ or −) indicates direction: a positive correlation means as one variable increases, the other tends to increase (e.g., age and chronic disease prevalence); a negative correlation means as one increases, the other tends to decrease (e.g., exercise frequency and body weight in many populations). The magnitude (absolute value) indicates strength: r = 0 means no linear relationship; r = ±0.3 to ±0.5 is weak to moderate; r = ±0.5 to ±0.7 is moderate to strong; r = ±0.7 to ±1.0 is strong to very strong. Example: A study finds a correlation of r = −0.65 between hours of sleep and medication administration errors in nurses, indicating a strong negative relationship—more sleep is associated with fewer errors. However, correlation does not prove causation; other factors (stress, workload, experience) might explain both sleep and errors. EFFECT SIZE quantifies the magnitude of an intervention's effect, answering 'How big is the difference?' A statistically significant result (p < 0.05) may have a small, clinically unimportant effect size, especially in large samples. Conversely, a non-significant result might have a meaningful effect size in a small sample (reflecting low statistical power rather than no effect). Effect sizes are reported as Cohen's d (for comparing means), odds ratio (for odds of an outcome), or correlation coefficient. Example: A study comparing two pain management interventions finds p = 0.03 (statistically significant). However, Cohen's d = 0.2 (small effect size), meaning the practical difference between interventions is minimal. Understanding effect size alongside p-value prevents over-interpreting statistically significant but clinically small effects.

Evidence-Based Practice (EBP) is the integration of the best available research evidence, clinical expertise, and patient values and preferences to guide clinical decisions and improve patient outcomes. EBP is not 'cookbook nursing'—following protocols blindly without clinical judgment. Rather, it is a thoughtful synthesis where research findings inform but do not replace professional judgment and consideration of the individual patient's circumstances, preferences, and cultural context. In the Philippines, EBP aligns with the professional competencies expected by the Board of Nursing and with the nation's health priorities. EBP has demonstrated benefits: improved patient outcomes, reduced variation in care, enhanced efficiency, lower costs, and greater patient satisfaction. The process of implementing EBP is often described using the FIVE A's: (1) ASK—Formulate a focused clinical question about a specific clinical problem. Questions are most useful when framed using PICO(T) format to clarify the Population, Intervention, Comparison, Outcome, and Time frame. Example question: In adult patients hospitalized with community-acquired pneumonia (P), does early mobilization (I) compared to standard bed rest (C) reduce hospital length of stay (O) and improve functional recovery (O) within 30 days (T)? A well-formulated question directs the evidence search and focuses the appraisal. (2) ACQUIRE—Search for the best available evidence through systematic searching of databases (PubMed, CINAHL, Cochrane Library), journals, practice guidelines, and expert consultation. The search should use relevant keywords and include recent publications (within 5–10 years, unless foundational classics). Filipino nurses can access PubMed and some journals through institutional libraries; organizations like the Philippine Nursing Association may provide access to key nursing databases. The goal is to find the strongest evidence available—ideally systematic reviews or RCTs, but other well-designed studies if those are unavailable. (3) APPRAISE—Critically appraise the evidence for validity (is it sound?), relevance (does it apply to my patient/setting?), and clinical importance (does it matter?). Appraisal involves assessing study quality (design, sample size, methods), bias (selection bias, measurement bias), generalizability (can I apply this finding to my patients?), and consistency (do multiple studies support the same finding?). Critical appraisal checklists (e.g., CASP—Critical Appraisal Skills Programme) help structure this review. Red flags for poor-quality evidence include: small sample sizes, convenience sampling, lack of control group, no measurement of important outcomes, significant dropout rates, or author bias. Conversely, markers of strong evidence include RCT or quasi-experimental design, large, representative sample, randomization, standardized outcome measures, low dropout, and multiple publications showing consistent results. (4) APPLY—Translate appraised evidence into practice, integrating it with clinical expertise and patient preferences. This step acknowledges that evidence alone does not determine practice; the clinician considers: Does this evidence fit my patient's unique circumstances, values, and preferences? Are there organizational or resource barriers to implementation? What is my clinical judgment based on experience with similar patients? Application also involves: Individualizing recommendations (a guideline may recommend medication X, but the patient with particular contraindications may need an alternative); Educating patients about the evidence and exploring their preferences; Monitoring outcomes to ensure the intervention is working for this particular patient; Adjusting if needed. In the Philippine context, this might mean adapting evidence-based recommendations to fit local resources (e.g., if the guideline recommends an expensive dressing unavailable in a rural setting, what locally available alternative has evidence support?). (5) ASSESS/EVALUATE—Evaluate the outcome of the EBP change. Did implementing the evidence-based recommendation improve the patient's outcome? Did it reduce errors, improve satisfaction, or advance clinical goals? Evaluation involves: Measuring relevant outcomes (patient outcomes, process measures, satisfaction); Comparing outcomes before and after implementation; Identifying facilitators and barriers to implementation; Disseminating results so others can learn. This evaluation closes the loop and generates local evidence about what works in your specific setting. THE HIERARCHY (LEVELS) OF EVIDENCE ranks research designs by their ability to produce strong evidence of cause and effect. Understanding this hierarchy helps nurses critically appraise and prioritize sources: Level 1 (Strongest): Systematic reviews and meta-analyses of Randomized Controlled Trials (RCTs). A systematic review is a rigorous, comprehensive search and synthesis of all available high-quality evidence on a topic, often resulting in a meta-analysis (statistical combination of results across studies). Systematic reviews are powerful because they combine the strength of multiple studies and reduce the influence of individual study limitations. Example: A Cochrane Systematic Review examining the effectiveness of hand hygiene interventions in reducing hospital-acquired infections across 50 RCTs. Level 2: Individual well-designed RCTs with adequate sample size and low dropout. RCTs are powerful because randomization controls for confounding variables and allows causal inference. Example: A single large RCT comparing two wound dressing protocols in 200 patients. Level 3: Controlled trials without randomization (Quasi-experimental studies). These studies have an intervention and comparison group but lack randomization, so causal inference is weaker. Example: A hospital implements a new fall prevention protocol for one unit and compares fall rates to a non-intervention unit, but patients are not randomly assigned. Level 4: Cohort and case-control studies. Cohort studies follow groups over time (prospective); case-control studies compare those with an outcome to those without, looking backward (retrospective). Both are observational and provide weaker causal evidence than RCTs but are useful when RCTs are not feasible. Example: A cohort study following nurses with high vs. low stress levels to compare rates of error or burnout over 2 years. Level 5: Systematic reviews of descriptive and qualitative studies. These reviews synthesize qualitative research on a topic, yielding rich understanding of experience, meaning, and context. Example: A systematic review of qualitative studies about patient experiences with chronic disease management. Level 6: Single descriptive or qualitative studies. A single qualitative study provides in-depth understanding of a phenomenon but cannot be generalized to all patients. Example: A phenomenological study exploring the lived experience of Filipino women with infertility. Level 7 (Weakest): Expert opinion and consensus statements. While expert opinion is valuable, it is not evidence-based and may reflect bias or outdated practices. Example: A statement by a nursing organization that based on clinical experience, nurses should provide hourly comfort rounds. When implementing EBP, seek evidence from the highest level possible; if Level 1 evidence is unavailable, move to Level 2, and so forth. However, recognize that the highest level is not always available for every clinical question, and the quality of a single well-conducted study may exceed the quality of a poorly conducted systematic review. EBP VERSUS RESEARCH: These terms are sometimes confused but are distinct. Research generates new knowledge through systematic inquiry; its goal is generalizable findings that advance the discipline. EBP applies existing best evidence to practice decisions; its goal is to improve outcomes in the specific clinical setting. Related but distinct: Quality Improvement (QI) is using local data to improve a specific process in a specific setting; it is not designed to generate generalizable knowledge. Example: A hospital tracks medication administration errors over 3 months, implements a specific intervention (e.g., double-check protocol), and measures errors again to see if the intervention helped that hospital. This is QI, not research, because the goal is local improvement, not generalizable knowledge. However, EBP and QI work together—EBP findings might inform QI efforts. BARRIERS AND FACILITATORS to EBP include: Barriers—Lack of time for nurses to search and appraise evidence; limited access to databases or journals; organizational culture that values traditional practice over innovation; insufficient staffing to implement changes; cost of new interventions or equipment; nurse knowledge gaps in research interpretation; patient resistance to change; lack of institutional support. In Philippine settings, barriers might include limited access to peer-reviewed databases, resource constraints in rural health facilities, and language barriers (much evidence is published in English). Facilitators—Nurse leadership that champions EBP; access to evidence (through institutional libraries or open-access journals); organizational structures supporting evidence appraisal (journal clubs, EBP committees); nurse education in research and EBP; interdisciplinary collaboration; patient involvement; adequate staffing and resources. Nurses can advocate for EBP by participating in journal clubs, questioning practices without evidence, suggesting EBP projects aligned with organizational priorities, and documenting outcomes of evidence-based changes. PRACTICAL APPLICATION in Clinical Settings: Journal Clubs—regular meetings where nurses discuss and critique current research. This builds evidence appraisal skills and spreads knowledge. Unit-Based EBP Projects—small, local projects addressing clinical questions relevant to a specific unit or patient population. Example: A maternal health unit implements evidence-based guidelines for preventing post-partum hemorrhage and measures outcomes. Clinical Practice Guidelines—systematically developed statements synthesizing evidence to guide clinical decisions. Many organizations (WHO, national health departments, professional associations) publish guidelines. Nurses use guidelines to standardize practice and ensure evidence-based care. Protocols and Pathways—step-by-step procedures based on evidence, such as sepsis protocols, pain management pathways, or post-operative care sequences. Adherence to evidence-based protocols improves consistency and reduces errors. Research Utilization Across the Healthcare Team—interdisciplinary teams (physicians, nurses, pharmacists, other providers) collaborate to implement evidence-based care. Shared understanding enhances implementation and patient outcomes.

Nursing research and evidence-based practice in the Philippines operate within a specific regulatory, cultural, and health system context. Understanding this context enhances the relevance and applicability of research and ensures ethical, culturally congruent care. REGULATORY FRAMEWORK: The Republic Act No. 9173 (RA 9173), the Philippine Nursing Law, establishes standards and competencies for registered nurses, including research and EBP competencies. Registered nurses are expected to: stay current with nursing knowledge and practice; participate in continuing professional development; contribute to nursing science through research participation or leadership; implement evidence-based interventions; and advocate for improved care quality. The Board of Nursing (PRC) incorporates research competencies in the NLE to ensure graduates can appraise and apply research. The Data Privacy Act of 2012 (RA 10173) is essential for research ethics in the Philippines. This law mandates the protection of personal information collected during research and imposes strict penalties for unauthorized disclosure. Researchers must obtain explicit consent for data collection, inform participants of how their data will be used, implement security measures, and provide mechanisms for individuals to access, correct, or delete their data. Health facilities conducting research must establish Ethics Review Committees (ERCs) and ensure all studies are reviewed and approved before beginning. The National Ethical Guidelines for Health and Health-Related Research (developed by PHREB/DOST) guide research ethics in the Philippines and align with international standards. HEALTH PRIORITIES AND RESEARCH FOCI: The Philippines Department of Health (DOH) and the Philippine Health Agenda identify priority health issues where research and EBP are critical: Maternal and Child Health—reducing maternal mortality, improving neonatal care, addressing malnutrition; Infectious Diseases—tuberculosis control, dengue fever management, responding to emerging infections; Non-Communicable Diseases—hypertension, diabetes, and cancer management; Mental Health—depression, anxiety, and suicide prevention; Health Emergency Preparedness—disaster response and pandemic readiness; Universal Health Care—improving access to quality care in underserved areas. Research and EBP in these areas are essential to achieving national health targets. CULTURAL CONSIDERATIONS: The Philippines is a diverse nation with distinct regional cultures, languages, and health beliefs. EBP in this context must be culturally congruent—respecting traditional healing practices while integrating evidence-based biomedical care. Examples of cultural health practices include: herbalism (use of medicinal plants); faith healing and spiritual practices; consultation with traditional healers (albularyo, hilot) alongside or instead of formal health care; family-centered decision-making (families often make health decisions collectively); reliance on informal social networks for health information. EBP that acknowledges these practices—understanding their role, identifying safe integration, and educating patients about evidence—is more likely to be accepted and effective. For example, if a diabetic patient uses traditional herbal remedies, a nurse might research evidence on those herbs, determine if they interact with prescribed medications, and work with the patient to develop a plan that respects their values while ensuring safe, effective glucose management. BARRIERS TO NURSING RESEARCH IN THE PHILIPPINES: Limited Access to Research Resources—rural and underserved health facilities have limited access to databases, journals, and research databases. Many nurses cannot access PubMed or specialty journals. Language Barrier—most high-impact research is published in English; nurses with limited English proficiency may struggle. Limited Research Capacity—few undergraduate nursing programs emphasize research skills; many nurses complete programs without formal research training. Resource Constraints—rural health centers lack funding for research projects, equipment, and staff time to participate in studies. Researcher Mobility—many nursing researchers work in academic/tertiary settings; fewer research opportunities exist in primary care and community settings. Competing Priorities—nurses in busy clinical settings prioritize direct patient care over research participation. OPPORTUNITIES AND FACILITATORS: Growing Recognition of EBP—the DOH and professional organizations increasingly emphasize EBP in policies and guidelines. Open-Access Resources—platforms like PubMed Central, HINARI (WHO program providing journal access to low-income countries), and Philippine universities offer growing access to evidence. Nursing Research Forums—the Philippine Nursing Research Society and annual PNA congresses provide venues for nurses to present and discuss research. International Collaboration—partnerships between Philippine universities and international researchers bring resources and expertise. Government Support—DOST and other agencies fund research addressing health priorities. Community-Based Research—participatory research approaches empower communities and build local research capacity. LOCAL RESEARCH IMPACT: Philippine nursing research increasingly addresses locally relevant questions. Examples include: Studies of Maternal Outcomes in Low-Resource Settings—examining maternal mortality, interventions to improve care access, and effectiveness of community health workers. Tuberculosis Management in the Community—exploring factors affecting treatment adherence, barriers to care, and community health worker effectiveness in TB-endemic regions. Care of Elderly Patients—addressing aging population needs, caregiver burden, and long-term care capacity in a culturally appropriate manner. Mental Health in Disaster Settings—studying psychological responses to typhoons and earthquakes, effective interventions, and community resilience. Integrative Care—examining how traditional and biomedical approaches can be safely integrated to respect cultural values while improving outcomes. Research disseminated through the Philippine Nursing Association, regional nursing conferences, and local publications influences practice. NURSE'S ROLE IN PROMOTING RESEARCH AND EBP: Reading and Appraising Published Research—staying current, understanding research terminology, and critically evaluating findings. Participating in Research—as research assistants, data collectors, or study participants, nurses support the generation of local evidence. Implementing Evidence-Based Protocols—using research-informed guidelines and documenting outcomes to demonstrate effectiveness. Advocating for EBP—questioning routines, proposing research-based changes, and supporting organizational EBP initiatives. Mentoring Others—sharing knowledge of research and EBP with colleagues, especially less experienced nurses. Conducting or Collaborating on Research—conducting small studies or quality improvement projects addressing clinical questions. Contributing to Policy—sharing research findings with policy makers to inform health policies and regulations. In the Philippines, where resources are often limited, nurses' contributions to research and EBP are particularly valuable. Even simple, well-conducted studies of local issues (e.g., 'Does this simpler infection control procedure, using locally available materials, reduce infection rates?') contribute to knowledge and improve care. Nurses who develop research and EBP competencies enhance their professional credibility, contribute to the discipline, and ultimately improve patient outcomes in Filipino health systems.

As you prepare for the NLE, certain concepts related to nursing research and EBP appear frequently in exams. Prioritize understanding these key points: RESEARCH DESIGNS: (1) True Experiment = Manipulation + Control Group + Randomization. If all three are present, causal inference is strongest. The RCT is the gold standard. (2) Quasi-Experimental = Manipulation but lacks randomization and/or control group. Weaker causal inference but often more feasible clinically. (3) Non-Experimental Designs (Descriptive, Correlational, Cohort, Case-Control, Cross-Sectional) = no manipulation; cannot establish causation but are useful for description and exploration. (4) Correlation ≠ Causation. A strong correlation between two variables does not prove one causes the other; confounding variables may explain the relationship. VARIABLES AND HYPOTHESES: (1) Independent Variable (IV) = cause/intervention/exposure (manipulated in experimental designs). (2) Dependent Variable (DV) = effect/outcome (measured). (3) Null Hypothesis (H0) = states no relationship/difference; is what statistical testing tries to reject. (4) Alternative/Research Hypothesis (H1) = states expected relationship/difference. (5) If p < 0.05, reject H0 (statistically significant). SAMPLING: (1) Probability Sampling (Simple Random, Systematic, Stratified, Cluster) = supports generalizability; each member has known, non-zero probability of selection. (2) Non-Probability Sampling (Convenience, Quota, Purposive, Snowball) = limits generalizability; selection not random. (3) Larger samples reduce sampling error and increase power. INSTRUMENT QUALITY: (1) Validity = instrument measures what it intends to measure (Content, Construct, Criterion validity). (2) Reliability = instrument yields consistent results (Test-Retest, Internal Consistency, Interrater reliability). (3) Reliable ≠ automatically valid (consistent but measuring wrong thing). (4) Not valid without reliable (if inconsistent, cannot measure anything accurately). ETHICS: (1) Informed Consent = voluntary, informed agreement with understanding of purpose, procedures, risks, benefits, confidentiality, and right to withdraw. (2) Confidentiality = researcher knows identity but protects data; Anonymity = identity unknown, data cannot be linked. (3) Vulnerable Populations: Children (parental consent + child assent); Pregnant Women (restricted research); Prisoners (restricted + safeguards); Cognitively Impaired (proxy + assent assessment); Critically Ill (family/proxy). (4) All research requires IRB/Ethics Review Committee approval before starting. (5) In Philippines: RA 10173 (Data Privacy Act), PHREB guidelines, institutional ERCs. STATISTICS: (1) Central Tendency: Mean (average, normal data), Median (middle, skewed data), Mode (most frequent, nominal data). (2) Normal Distribution: 68% within ±1 SD, 95% within ±2 SD, 99.7% within ±3 SD. (3) p < 0.05 = statistically significant (reject H0). (4) Type I Error = false positive; Type II Error = false negative. (5) Correlation coefficient (r) ranges −1.0 to +1.0: sign = direction, magnitude = strength. (6) Statistical significance ≠ clinical significance (consider effect size). EBP: (1) EBP = Best Evidence + Clinical Expertise + Patient Values. (2) Five A's: ASK (PICO), ACQUIRE, APPRAISE, APPLY, ASSESS. (3) Hierarchy of Evidence: Systematic Reviews of RCTs (strongest) → RCTs → Quasi-Experimental → Cohort/Case-Control → Qualitative Reviews → Single Qualitative Studies → Expert Opinion (weakest). (4) EBP differs from Research (generates knowledge) and QI (improves local process). PHILIPPINE CONTEXT: (1) RA 9173 establishes research/EBP competencies for RNs. (2) RA 10173 mandates data privacy protection. (3) PHREB Guidelines guide ethical research. (4) EBP must be culturally congruent, respecting traditional practices. (5) Priority areas: Maternal/Child Health, Infectious Diseases, NCD, Mental Health, Emergency Preparedness.